Wird geladen...
Rituximab in Membranous Nephropathy
Membranous nephropathy (MN) is the most common cause of primary nephrotic syndrome among adults. The identification of phospholipase A2 receptor (PLA2R) as target antigen in most patients changed the management of MN dramatically, and provided a rationale for B-cell depleting agents such as rituxima...
Gespeichert in:
| Veröffentlicht in: | Kidney Int Rep |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Elsevier
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8071613/ https://ncbi.nlm.nih.gov/pubmed/33912740 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2020.12.035 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|